Read Full Article
Company developing a Next Generation Treatment for Low Testosterone. CENTENNIAL, Colo., Nov. 13, 2018 (GLOBE NEWSWIRE) -- IASO BioMed, ...
We are extremely pleased to welcome Drs. Blumenthal, Kacker, Mermelstein and Zirkin to join Drs. Papadopoulos and Karatzas on the IASO Scientific Advisory Board.
We believe the extensive knowledge and experience of our SAB will prove invaluable as IASO works to develop our first-in-class products for global markets.